Urology Care Foundation - Prostate Cancer: Early Detection for Higher Risk Patients with Dr. Brian McNeil and Dr. Paul Maroni

Advertisement

Centro de recursos Patient Magazine Podcast Donate

Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Prostate Cancer: Early Detection for Higher Risk Patients with Dr. Brian McNeil and Dr. Paul Maroni

Headshots of Dr. Brian McNeil and Dr. Paul Maroni

Our two guests on this podcast episode talk about prostate cancer and early detection for higher risk patients. Dr. McNeil shares his personal story around prostate cancer and how that led him to become a urologist who helps treat men with this disease. Dr. Maroni then joins in to talk about his work in the prostate cancer space while then going into more detail with Dr. McNeil on prostate cancer screenings, early detection for higher risk patients and how disparities affect care.

Short on time? Use the below timestamps to jump to any section:
0:54 - Introduction
1:26 - Dr. McNeil personal story
5:35 - Dr. Maroni's work in prostate cancer space
8:25 - Prostate cancer overview and symptoms
10:44 - Risk factors
13:16 - Prostate cancer screenings
16:43 - Treatment options
18:40 - Disparities in medical field
22:13 - Impact of disparities on clinical practices
25:57 - Advice to patients and caregivers
27:53 - Final thoughts

For more information, please subscribe to our free digital magazine, UrologyHealth extra.

This podcast is part of an educational series supported by independent educational grants from Astellas, Bayer HealthCare Pharmaceuticals, Genentech, Janssen Biotech (administered by Janssen Scientific Affairs), Merck and Pfizer.

****
September 23, 2021


Explore Further

Share Your Story

Have a story to share? The Urology Care Foundation invites you to share your experience with a urologic condition and how it has affected you or your family.

Make a Differnece

Your tax-deductible gift will help support the millions of patients who are faced with urologic disease. Together, we care.